MedTrace Logo

Cardiopulmonary Exercise Testing in Interstitial Lung Disease

NCT02636452 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2018-10-29

No results posted yet for this study

Summary

In patients with Interstitial lung diseases (ILD) dyspnea is the most often symptom. Pulmonary lung function tests often do not Show the dyspnea. Aim of the study is to evaluate cardiopulmonary exercise testing concerning therapeutic Monitoring in ILD.

Conditions

Interventions

OTHER

cardiopulmonary exercise test

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Wissenschaftliches Institut Bethanien e.V

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02636452 on ClinicalTrials.gov